Glenn J Jaffe Selected Research

Fluocinolone Acetonide (Capex)

10/2020	Effect of a Fluocinolone Acetonide Insert on Recurrence Rates in Noninfectious Intermediate, Posterior, or Panuveitis: Three-Year Results.
5/2020	Time to disease recurrence in noninfectious uveitis following long-acting injectable fluocinolone acetonide implant.
1/2019	Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment: Twelve-Month Results.
1/2019	MUST Beg to Differ.
1/2016	Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
12/2015	Improved Surgical Success of Combined Glaucoma Tube Shunt and Retisert(®) Implantation in Uveitic Eyes: A Retrospective Study.
1/2012	Prospective study of a fluocinolone acetonide implant for chronic macular edema from central retinal vein occlusion: thirty-six-month results.
11/2011	Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony.
5/2010	Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
10/2008	Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Glenn J Jaffe Research Topics

Disease

55	Macular Degeneration (Age-Related Maculopathy) 11/2022 - 01/2005
27	Macular Edema 01/2022 - 09/2003
25	Uveitis 01/2021 - 07/2002
16	Inflammation (Inflammations) 01/2022 - 06/2002
12	Atrophy 01/2022 - 09/2011
11	Geographic Atrophy 11/2022 - 04/2011
11	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2012
11	Panuveitis 01/2021 - 08/2005
10	Retinal Perforations 11/2021 - 01/2004
10	Cicatrix (Scar) 01/2021 - 03/2014
10	Posterior Uveitis 01/2021 - 07/2005
9	Glaucoma 12/2017 - 09/2003
8	Cataract (Cataracts) 10/2020 - 07/2005
7	Choroidal Neovascularization 07/2017 - 01/2004
6	Proliferative Vitreoretinopathy 08/2011 - 03/2003
4	Telangiectasis (Telangiectasia) 01/2022 - 01/2017
4	Intermediate Uveitis (Chronic Cyclitis) 01/2021 - 10/2008
4	Neoplasms (Cancer) 10/2018 - 06/2002
3	Disease Progression 01/2021 - 02/2013
3	Edema (Dropsy) 01/2019 - 06/2003
3	Retinal Detachment (Retinal Detachments) 01/2017 - 11/2002
3	Epiretinal Membrane (Epiretinal Membranes) 01/2017 - 02/2003
3	Retinal Vein Occlusion 01/2012 - 09/2003
2	Polypoidal Choroidal Vasculopathy 01/2022 - 12/2019
2	Retinal Vasculitis 01/2022 - 01/2021
2	Endophthalmitis (Ophthalmia) 01/2021 - 02/2009
2	Retinal Diseases 01/2020 - 08/2011
2	Hypersensitivity (Allergy) 03/2017 - 07/2002
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2015 - 09/2003
2	Cysts 10/2015 - 01/2004
2	Infections 03/2003 - 06/2002
1	Optic Nerve Diseases (Optic Neuropathy) 09/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2021
1	Hypopigmentation (Hypomelanosis) 01/2020
1	Hyperpigmentation 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Necrosis 01/2020
1	Fibrosis (Cirrhosis) 12/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019

Drug/Important Bio-Agent (IBA)

46	Retinaldehyde (Retinal)IBA 11/2022 - 06/2003
22	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2013
18	Ranibizumab (Lucentis)FDA Link 01/2022 - 05/2011
17	Fluocinolone Acetonide (Capex)FDA LinkGeneric 10/2020 - 07/2005
14	Fluorescein (Funduscein)FDA LinkGeneric 09/2021 - 02/2013
13	afliberceptIBA 01/2022 - 01/2014
13	Bevacizumab (Avastin)FDA Link 01/2022 - 05/2011
9	Pharmaceutical PreparationsIBA 01/2021 - 07/2005
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2008
7	Retinal Pigments (Pigments, Visual)IBA 01/2020 - 03/2003
6	brolucizumabIBA 01/2022 - 01/2017
6	microplasminIBA 01/2019 - 09/2012
5	Adalimumab (Humira)FDA Link 01/2021 - 09/2016
4	SteroidsIBA 01/2021 - 12/2016
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	salicylhydroxamic acid (SHAM)IBA 10/2020 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
3	Platelet-Derived Growth FactorIBA 05/2020 - 01/2016
3	Ciliary Neurotrophic Factor (CNTF)IBA 01/2019 - 04/2011
3	fluocinoloneIBA 04/2008 - 07/2005
2	N-acetyltryptophanamide (NATA)IBA 01/2022 - 10/2021
2	AntibodiesIBA 01/2022 - 10/2018
2	Complement System Proteins (Complement)IBA 01/2021 - 07/2009
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2019 - 07/2017
2	nepafenac (Nevanac)FDA Link 01/2017 - 01/2012
2	SuspensionsIBA 01/2017 - 01/2012
2	Prednisone (Sone)FDA LinkGeneric 09/2016 - 09/2016
2	GlucocorticoidsIBA 09/2016 - 12/2007
2	Oxidants (Oxidizing Agents)IBA 07/2009 - 10/2006
2	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 02/2009 - 09/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007 - 07/2004
2	Messenger RNA (mRNA)IBA 07/2007 - 07/2002
2	CytokinesIBA 07/2007 - 03/2003
1	risuteganibIBA 11/2022
1	Neurofibromin 2 (Merlin)IBA 01/2022
1	Plasma KallikreinIBA 12/2021
1	perflutren (octafluoropropane)FDA Link 11/2021
1	sarilumabIBA 09/2021
1	HSP27 Heat-Shock ProteinsIBA 01/2020
1	NucleotidesIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Heme Oxygenase-1IBA 01/2020
1	Immunoglobulin FragmentsIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Actins (F Actin)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020

Therapy/Procedure

21	Therapeutics 10/2020 - 03/2003
12	Injections 09/2021 - 11/2002
7	Traction 11/2021 - 01/2004
6	Intravitreal Injections 01/2022 - 09/2003
6	Vitrectomy 01/2017 - 06/2002
5	Aftercare (After-Treatment) 09/2021 - 09/2009
4	Lasers (Laser) 11/2016 - 09/2011
3	Light Coagulation 01/2019 - 10/2015
3	Cataract Extraction 01/2012 - 07/2005
2	Photochemotherapy (Photodynamic Therapy) 07/2017 - 01/2005
2	Brachytherapy 08/2013 - 02/2013
2	Filtering Surgery 10/2008 - 06/2006